Trial · NCT01664923
Participant flow16
How many started, completed or left each group, period by period.
1 to 16 of 16
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period1:Double Blind Phase-29 Months | STARTED | Enzalutamide | 198 | |
| Period1:Double Blind Phase-29 Months | STARTED | Bicalutamide Then Enzalutamide | 198 | |
| Period1:Double Blind Phase-29 Months | Received Study Treatment | Enzalutamide | 197 | |
| Period1:Double Blind Phase-29 Months | Received Study Treatment | Bicalutamide Then Enzalutamide | 198 | |
| Period1:Double Blind Phase-29 Months | COMPLETED | Enzalutamide | 93 | |
| Period1:Double Blind Phase-29 Months | COMPLETED | Bicalutamide Then Enzalutamide | 38 | |
| Period1:Double Blind Phase-29 Months | NOT COMPLETED | Enzalutamide | 105 | |
| Period1:Double Blind Phase-29 Months | NOT COMPLETED | Bicalutamide Then Enzalutamide | 160 | |
| Period 2: Open-label Phase-36 Months | STARTED | Enzalutamide | 93 | |
| Period 2: Open-label Phase-36 Months | STARTED | Bicalutamide Then Enzalutamide | 38 | |
| Period 2: Open-label Phase-36 Months | Treated | Enzalutamide | 93 | |
| Period 2: Open-label Phase-36 Months | Treated | Bicalutamide Then Enzalutamide | 37 | |
| Period 2: Open-label Phase-36 Months | COMPLETED | Enzalutamide | 52 | |
| Period 2: Open-label Phase-36 Months | COMPLETED | Bicalutamide Then Enzalutamide | 15 | |
| Period 2: Open-label Phase-36 Months | NOT COMPLETED | Enzalutamide | 41 | |
| Period 2: Open-label Phase-36 Months | NOT COMPLETED | Bicalutamide Then Enzalutamide | 23 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01664923/flow